0
     

Report Added
Report already added
Dynamics in Post-pandemic Global Pediatric Drugs and Vaccines Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global Pediatric Drugs and Vaccines Industry: Supply and Demand, Markets and Prices 2021-2027

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Pediatric Drugs and Vaccines market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Pediatric Drugs and Vaccines market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others

Segmented by End User/Segment
Newborn
Infant
Child

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Takeda
Shionogi Inc. (USA)
Sanofi S.A (France)
Pfizer, Inc. (USA)
Novo Nordisk A/S (Denmark)
Novartis AG (Switzerland)
Merck & Co., Inc. (USA)
Janssen Biologics B.V. (USA)
GlaxoSmithKline plc. (UK)
Genentech, Inc. (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Eli Lilly and Company (USA)
Bristol-Myers Squibb Company (USA)
Boehringer Ingelheim GmbH (Germany)
AstraZeneca Plc. (UK)
Amgen, Inc. (USA)
Allergan, Inc. (USA)
Actelion Pharmaceuticals
Abbott Laboratories (USA)

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Pediatric Drugs and Vaccines Market Status and Forecast (2016-2027)
1.3.2 Global Pediatric Drugs and Vaccines Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Pediatric Drugs and Vaccines Supply by Company
2.1 Global Pediatric Drugs and Vaccines Sales Volume by Company
2.2 Global Pediatric Drugs and Vaccines Sales Value by Company
2.3 Global Pediatric Drugs and Vaccines Price by Company
2.4 Pediatric Drugs and Vaccines Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Pediatric Drugs and Vaccines Market Status by Category
3.1 Pediatric Drugs and Vaccines Category Introduction
3.1.1 Diphtheria
3.1.2 Influenza
3.1.3 Hepatitis
3.1.4 Pneumococcal Diseases
3.1.5 Meningococcal Diseases
3.1.6 Mumps
3.1.7 Others
3.2 Global Pediatric Drugs and Vaccines Market by Category
3.2.1 Global Pediatric Drugs and Vaccines Sales Volume by Category (2016-2021)
3.2.2 Global Pediatric Drugs and Vaccines Sales Value by Category (2016-2021)
3.2.3 Global Pediatric Drugs and Vaccines Price by Category (2016-2021)
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional Pediatric Drugs and Vaccines Market Status by End User/Segment
4.1 Pediatric Drugs and Vaccines Segment by End User/Segment
4.1.1 Newborn
4.1.2 Infant
4.1.3 Child
4.2 Global Pediatric Drugs and Vaccines Market by End User/Segment
4.2.1 Global Pediatric Drugs and Vaccines Sales Volume by End User/Segment (2016-2021)
4.2.2 Global Pediatric Drugs and Vaccines Sales Value by End User/Segment (2016-2021)
4.2.3 Global Pediatric Drugs and Vaccines Price by End User/Segment (2016-2021)
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global Pediatric Drugs and Vaccines Market Status by Region
5.1 Global Pediatric Drugs and Vaccines Market by Region
5.1.1 Global Pediatric Drugs and Vaccines Sales Volume by Region
5.1.2 Global Pediatric Drugs and Vaccines Sales Value by Region
5.2 North America Pediatric Drugs and Vaccines Market Status
5.3 Europe Pediatric Drugs and Vaccines Market Status
5.4 Asia Pacific Pediatric Drugs and Vaccines Market Status
5.5 Central & South America Pediatric Drugs and Vaccines Market Status
5.6 Middle East & Africa Pediatric Drugs and Vaccines Market Status
6 North America Pediatric Drugs and Vaccines Market Status
6.1 North America Pediatric Drugs and Vaccines Market by Country
6.1.1 North America Pediatric Drugs and Vaccines Sales Volume by Country (2016-2021)
6.1.2 North America Pediatric Drugs and Vaccines Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Pediatric Drugs and Vaccines Market Status
7.1 Europe Pediatric Drugs and Vaccines Market by Country
7.1.1 Europe Pediatric Drugs and Vaccines Sales Volume by Country (2016-2021)
7.1.2 Europe Pediatric Drugs and Vaccines Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Pediatric Drugs and Vaccines Market Status
8.1 Asia Pacific Pediatric Drugs and Vaccines Market by Country
8.1.1 Asia Pacific Pediatric Drugs and Vaccines Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Pediatric Drugs and Vaccines Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Pediatric Drugs and Vaccines Market Status
9.1 Central & South America Pediatric Drugs and Vaccines Market by Country
9.1.1 Central & South America Pediatric Drugs and Vaccines Sales Volume by Country (2016-2021)
9.1.2 Central & South America Pediatric Drugs and Vaccines Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Pediatric Drugs and Vaccines Market Status
10.1 Middle East & Africa Pediatric Drugs and Vaccines Market by Country
10.1.1 Middle East & Africa Pediatric Drugs and Vaccines Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Pediatric Drugs and Vaccines Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Pediatric Drugs and Vaccines Manufacturing Cost Analysis
11.5 Pediatric Drugs and Vaccines Sales Channel and Distributors Analysis
11.5.1 Pediatric Drugs and Vaccines Sales Channel
11.5.2 Pediatric Drugs and Vaccines Distributors
11.6 Pediatric Drugs and Vaccines Downstream Major Buyers
12 Global Pediatric Drugs and Vaccines Market Forecast by Category and by End User/Segment
12.1 Global Pediatric Drugs and Vaccines Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Pediatric Drugs and Vaccines Forecast by Category
12.2.1 Global Pediatric Drugs and Vaccines Sales Volume Forecast by Category
12.2.2 Global Pediatric Drugs and Vaccines Sales Value Forecast by Category
12.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Category
12.3 Global Pediatric Drugs and Vaccines Forecast by End User/Segment
12.3.1 Global Pediatric Drugs and Vaccines Sales Volume Forecast by End User/Segment
12.3.2 Global Pediatric Drugs and Vaccines Sales Value Forecast by End User/Segment
12.3.3 Global Pediatric Drugs and Vaccines Price Forecast by End User/Segment
13 Global Pediatric Drugs and Vaccines Market Forecast by Region/Country
13.1 Global Pediatric Drugs and Vaccines Market Forecast by Region (2022-2027)
13.1.1 Global Pediatric Drugs and Vaccines Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Pediatric Drugs and Vaccines Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Takeda
14.1.1 Company Information
14.1.2 Pediatric Drugs and Vaccines Product Introduction
14.1.3 Takeda Pediatric Drugs and Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Shionogi Inc. (USA)
14.2.1 Company Information
14.2.2 Pediatric Drugs and Vaccines Product Introduction
14.2.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Sanofi S.A (France)
14.3.1 Company Information
14.3.2 Pediatric Drugs and Vaccines Product Introduction
14.3.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Pfizer, Inc. (USA)
14.4.1 Company Information
14.4.2 Pediatric Drugs and Vaccines Product Introduction
14.4.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Novo Nordisk A/S (Denmark)
14.5.1 Company Information
14.5.2 Pediatric Drugs and Vaccines Product Introduction
14.5.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Novartis AG (Switzerland)
14.6.1 Company Information
14.6.2 Pediatric Drugs and Vaccines Product Introduction
14.6.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Merck & Co., Inc. (USA)
14.7.1 Company Information
14.7.2 Pediatric Drugs and Vaccines Product Introduction
14.7.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Janssen Biologics B.V. (USA)
14.8.1 Company Information
14.8.2 Pediatric Drugs and Vaccines Product Introduction
14.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 GlaxoSmithKline plc. (UK)
14.9.1 Company Information
14.9.2 Pediatric Drugs and Vaccines Product Introduction
14.9.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 Genentech, Inc. (USA)
14.10.1 Company Information
14.10.2 Pediatric Drugs and Vaccines Product Introduction
14.10.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
14.11 F. Hoffmann-La Roche Ltd (Switzerland)
14.12 Eli Lilly and Company (USA)
14.13 Bristol-Myers Squibb Company (USA)
14.14 Boehringer Ingelheim GmbH (Germany)
14.15 AstraZeneca Plc. (UK)
14.16 Amgen, Inc. (USA)
14.17 Allergan, Inc. (USA)
14.18 Actelion Pharmaceuticals
14.19 Abbott Laboratories (USA)
15 Conclusion
16 Methodology

Kindly Fill The Form Below

Report Title: Dynamics in Post-pandemic Global Pediatric Drugs and Vaccines Industry: Supply and Demand, Markets and Prices 2021-2027


Valid Invalid number
GRD Survey

Related Report

2021-2025 Vietnam Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Vietnam Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Venezuela Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Venezuela Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Uruguay Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Uruguay Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 United Arab Emirates Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 United Arab Emirates Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Ukraine Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Ukraine Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


2021-2025 Turkey Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021-2025 Turkey Blood Banking Analyzers and Reagents Market-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


SELECT A FORMAT

ADD TO CART BUY NOW